Advertisement
UK markets closed
  • FTSE 100

    8,046.14
    +22.27 (+0.28%)
     
  • FTSE 250

    19,783.72
    +184.33 (+0.94%)
     
  • AIM

    755.74
    +6.56 (+0.88%)
     
  • GBP/EUR

    1.1624
    +0.0035 (+0.31%)
     
  • GBP/USD

    1.2432
    +0.0082 (+0.66%)
     
  • Bitcoin GBP

    53,486.82
    +401.44 (+0.76%)
     
  • CMC Crypto 200

    1,437.10
    +22.34 (+1.58%)
     
  • S&P 500

    5,061.44
    +50.84 (+1.01%)
     
  • DOW

    38,426.52
    +186.54 (+0.49%)
     
  • CRUDE OIL

    82.56
    +0.66 (+0.81%)
     
  • GOLD FUTURES

    2,335.20
    -11.20 (-0.48%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,142.58
    +281.78 (+1.58%)
     
  • CAC 40

    8,110.41
    +70.05 (+0.87%)
     

Alphabet's Verily raises $700 million in funding round

FILE PHOTO: File photo of a Google search page is seen through a magnifying glass in this photo illustration taken in Berlin

(Reuters) - Alphabet Inc's life sciences division, Verily Life Sciences LLC, said it raised $700 million in a funding round from its investors including Alphabet, Silver Lake and Temasek.

The company said it would expand its commercial businesses, Baseline and Verily Health Platforms, with the funding received.

Verily, which integrates data and technology with healthcare, had also developed a COVID-19 test, which was granted an emergency use authorization by the U.S. Food and Drug Administration in September. (https://reut.rs/34pMzl8)

(Reporting by Chavi Mehta in Bengaluru; Editing by Devika Syamnath)